Systematic overview of hepatitis C infection in the Middle East and North Africa

Table 3 Hepatitis C antibody prevalence evidence gap mapping with quality assessment, Fertile Crescent region

	Iraq	Jordan	Lebanon	Palestine	Syria
General population	0.0%-4.0 % (2004-2012)1	No data	0.6%-2.9% (-)2	No data	2.8% (2004)1
Blood donors	0.2%-2.8% (2003-2013)1	0.1%-0.9% (2003-2011)1	0.0%-3.4% (< 2003)1	0.2%-0.3% (2003-2013)1	0.4% (2000-2011)1
Pregnant women	0.0%-5.1% (2004-2010)1	No data	No data	No data	No data
Children	0.0% (2007-2009)1	No data	No data	No data	No data
Hemodialysis, renal dialysis, and/or dialysis patients	4.9%-42.6% (2002-2011)1	21.0%-49.8% (2003-2008)1	16.0%-27.0% (-)2	17.9%-27.4% (2007-2013)1	21.0% (2006)1
Hemophiliac or other bleeding disorder patients	6.7%-40.3% (2006-2012)1	No data	10.0% (-)3	No data	20.5% (2007-2011)1
Transfused patients	3.4%-4.5% (2004-2008)1	No data	No data	No data	13.3% (2000)2
Thalassemic patients	4.0%-46.0% (2003-2012)1	32.8% (2008)1	0.0%-14.0% (> 1999)1	No data	No data
Patients with hepatocellular carcinoma	26.1% (2000-2003)2	No data	19.6% (1998-2003)2	No data	No data
Patients with acute liver disease	0.0%-71.9% (2007-2011)1	No data	No data	No data	1.0%(1995-1998)1
Patients with chronic liver disease	3.8%-62.0% (2005-2009)1	No data	No data	No data	No data
Healthcare workers	0.0%-9.1% (2002-2010)1	0.7% (1999)1	0.4% (1999)1	No data	3.0%-3.8% (-)2
Barbers	0.3% (1999-2001)1	No data	No data	No data	No data
Contact of patients with hepatitis C	1.2%-1.4% (1996-2001)1	No data	No data	No data	No data
People who inject drugs	No data	No data	52.8% (2007-2008)1	45.2% (2010)1	60.5% (-)3
Prisoners	0.6% (1996-2001)1	No data	3.4% (-)3	No data	No data
Patients with HIV and/or other sexually transmitted infection	1.2% (-)2	No data	7.7% (-)3	No data	No data
Sex workers	No data	No data	0.0% (2007-2008)1	No data	2.0% (-)2
Men who have sex with men	No data	No data	0.0% (2007-2008)1	No data	No data

Prevalence, year of data collection.

¹Good quality;

²Average quality;

³Poor quality.